Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Diego, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Oncternal Therapeutics, Inc. has filed 1,606 SEC EDGAR filings since 21 Aug 2003

SEC filing history

Showing 926-950 of 1,000 matching filings.

Per page
25
Current page
38
4

FORM 4 SUBMISSION

Filing date
03 Mar 2011
Reporting date
02 Mar 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50549

FORM 8-K

Filing date
02 Mar 2011
Reporting date
01 Mar 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50549

FORM 8-K

Filing date
24 Feb 2011
Reporting date
24 Feb 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50549

FORM 8-K

Filing date
22 Feb 2011
Reporting date
17 Feb 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-79588

SC 13D/A

Filing date
15 Feb 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-79588

SC 13D/A

Filing date
15 Feb 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-79588

SC 13G/A

Filing date
14 Feb 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
09 Feb 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-79588

AMENDMENT NO. 5

Filing date
08 Feb 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
19 Jan 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
10 Jan 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Jan 2011
Reporting date
01 Jan 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
04 Jan 2011
Reporting date
01 Jan 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Jan 2011
Reporting date
01 Jan 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Jan 2011
Reporting date
01 Jan 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Jan 2011
Reporting date
01 Jan 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Jan 2011
Reporting date
01 Jan 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Jan 2011
Reporting date
01 Jan 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Jan 2011
Reporting date
01 Jan 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Jan 2011
Reporting date
01 Jan 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Jan 2011
Reporting date
01 Jan 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Jan 2011
Reporting date
01 Jan 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Jan 2011
Reporting date
01 Jan 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Jan 2011
Reporting date
01 Jan 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Jan 2011
Reporting date
01 Jan 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .